This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
Data supporting this study’s findings would be available on request from the corresponding author [MQS].
References
Salas MQ, Charry P, Pedraza A, Martinez-Cibrian N, Solano MT, Domenech A, et al. PTCY and Tacrolimus for GVHD prevention for older adults undergoing HLA-matched sibling and unrelated donor AlloHCT. Transpl Cell Ther. 2022;28:489 e1–e9.
Nunes NS, Kanakry CG. Mechanisms of Graft-versus-Host disease prevention by post-transplantation cyclophosphamide: an evolving understanding. Front Immunol. 2019;10:2668.
Clifton K, Barnett C, Martinez A, Karuturi M, Saleem S, Litton J. Severe hyponatremia following cyclophosphamide infusion in breast cancer patients. Breast J. 2018;24:691–2.
Bruining DM, van Roon EN, de Graaf H, Hoogendoorn M. Cyclophosphamide-induced symptomatic hyponatraemia. Neth J Med. 2011;69:192–5.
Lee YC, Park JS, Lee CH, Bae SC, Kim IS, Kang CM, et al. Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transpl. 2010;25:1520–4.
Teles KA, Medeiros-Souza P, Lima FAC, Araujo BG, Lima RAC. Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review. Rev Bras Reumatol Engl Ed. 2017;57:596–604.
Chen J, Jin Y, Li C, Li Z. Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: a case report. Medicine. 2020;99:e22498.
Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A. Medication-induced SIADH: distribution and characterization according to medication class. Br J Clin Pharm. 2017;83:1801–7.
Park SJ, Kim JH, Shin JI. Insight on mechanism of hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transpl. 2010;25:3453.
Kim S, Jo CH, Kim GH. The role of vasopressin V2 receptor in drug-induced hyponatremia. Front Physiol. 2021;12:797039.
Koo TY, Bae SC, Park JS, Lee CH, Park MH, Kang CM, et al. Water intoxication following low-dose intravenous cyclophosphamide. Electrolyte Blood Press. 2007;5:50–4.
Acknowledgements
We thank our patients and the nursing and support staff in the Hematopoietic Cell Transplant Program and the Nephrology Medical Department at Hospital Clinic de Barcelona.
Author information
Authors and Affiliations
Contributions
MG and MQS designed the study, interpreted the results, and wrote the letter. MG collected the data and did the statistical analysis. LQ, MSL, NMC, AR, SR, EC, PM, GR, IMAS, MTS, LR, JE, AUI, EC, FFA, CM and MR provided valuable input into the study and reviewed and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gómez-Hernando, M., Quintana, L.F., Suárez-Lledo, M. et al. Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 58, 212–214 (2023). https://doi.org/10.1038/s41409-022-01864-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-022-01864-7